DNA methylation biomarker for prostate cancer shows promise for accurately determining a patient's risk
Thursday, December 8, 2016 - 10:01
in Health & Medicine
Analysis consistently shows elevated PITX2 methylation associated with the presence of a prostate tumor, reports a research team, suggesting an advance in determining a patient's risk.